Peptide Decoding

Tesamorelin + Ipamorelin blend 8 mg vial price

Tesamorelin + Ipamorelin blend 8 mg vials are listed by 7 vendors. Prices run from $65.00 to $115.00, with a median of $90.00, across the 6 showing an exact in-stock price. Last read Oct 31, 2026.

Read the regulatory status before you compare prices.

Tesamorelin on its own is FDA-approved as EGRIFTA, EGRIFTA SV and EGRIFTA WR, for HIV-associated lipodystrophy. Ipamorelin is not approved for anything, and was moved to FDA compounding Category 2. The blend has never been tested in a human trial. An approval that one ingredient holds does not carry over to a combination it was never studied in.

What a 8 mg vial costs

Every vendor we track that lists this exact size, cheapest first. Sort order is price only; affiliate status never changes it.

Median $90.00 a vial, or $11.25 per mg, across the 6 vendors with an exact, in-stock price.

Median unchanged from Oct 31, 2026.

Testing checks: outside lab · HPLC purity · mass spec identity · batch COA · lab named

Sort by

We earn from these links. It never changes a price or a position here.

  • Oath Research: Stock not shown, left out of the range

Where the price has been

Market median at 8 mg: $12.82 per mg on Sep 12, 2026, $11.25 on Nov 5, 2026, 6 stores comparable today.

$12.82$8.13Sep 12, 2026Nov 5, 2026
Market median per mgLowest per mg
DateMedian per mgLow per mgStores
Nov 5, 2026$11.25$8.136
Oct 31, 2026$11.25$8.136
Oct 24, 2026$11.25$8.136
Oct 22, 2026$11.25$8.135
Oct 21, 2026$11.25$8.135
Oct 20, 2026$11.25$8.135
Oct 19, 2026$11.25$8.135
Oct 18, 2026$11.25$11.253